Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,281 public trials 1,202 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Recruiting

A First-in-human Study of PRTH-101 Monotherapy +/- Pembrolizumab in Subjects With Advanced Malignancies

NCT05753722

Conditions
Advanced or Metastatic Solid Tumors, Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
Locations
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Mass General Cancer Center Boston, Massachusetts, United States
  • Providence Cancer Institute Franz Clinic Portland, Oregon, United States
View Trial Details
Recruiting

A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer

NCT07428044

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations
  • University of Michigan (Data Collection Only) Ann Arbor, Michigan, United States
  • Mayo Clinic (Data Collection Only) Rochester, Minnesota, United States
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
View Trial Details
Recruiting

177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors

NCT06305962

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +46 more
Locations
  • Nepean Hospital Kingswood, New South Wales, Australia
  • Wollongong Hospital Wollongong, New South Wales, Australia
  • Gold Coast University Hospital Southport, Queensland, Australia
  • Cancer Research SA (CRSA) Adelaide, South Australia, Australia
View Trial Details
Recruiting

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

NCT07030257

Conditions
Bladder Cancer, Bronchial Neoplasms, Carcinoma, +47 more
Locations
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Florida Cancer Specialists-Lake Nona Orlando, Florida, United States
  • START Midwest Grand Rapids, Michigan, United States
  • Washington University St Louis, Missouri, United States
View all 13 locations
View Trial Details
Recruiting

Immune Profile Selection By Fraction of ctDNA in Patients With Advanced NSCLC Treated With Immunotherapy

NCT05715229

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Lombardi Comprehensive Cancer Center, Georgetown University Washington D.C., District of Columbia, United States
  • John Theurer Cancer Center, Hackensack Meridian Health Hackensack, New Jersey, United States
  • Jersey Shore University Medical Center Neptune City, New Jersey, United States
View Trial Details

Related conditions